February 18, 2009

SpeculatingStocks.com Stock Pick: Questcor Pharmaceuticals, Inc. (QCOR)

Stock Price: $7.27

Questcor Pharmaceuticals, Inc. is a pharmaceutical company that markets two commercial products, H.P. Acthar® Gel (``Acthar'') and Doral®. Acthar (repository corticotropin injection) is an injectable drug that is approved for the treatment of certain disorders with an inflammatory component. Doral is indicated for the treatment of insomnia characterized by difficulty in falling asleep, frequent nocturnal awakenings, and/or early morning awakenings.

QCOR will be reporting fourth quarter earnings on Tuesday, February 24th after the close. QCOR has grown revenue from $12.78 million in 2006 to $49.76 million in 2007 and has reported revenue of $68.23 million during the first three quarters of 2008.

QCOR has high profit margins built into their business. QCOR's net income over the last three quarters has come in at $24.29. QCOR is trading at a PE of only around 10 and has a market cap of less than $500 million.

QCOR has been in an uptrend since the beginning of February and could break out in the near future. Its chart is looking attractive with its 50-day moving average right above at $7.58.